How should I approach the management of a patient with Duchenne muscular dystrophy regarding corticosteroid therapy?

The management of a patient with Duchenne muscular dystrophy regarding corticosteroid therapy has historically included the use of corticosteroids [ (Moxley RT 3rd et al., 2005) ]. While specific current UK guidelines on corticosteroid therapy for Duchenne muscular dystrophy are not provided in the context, general principles for managing patients on oral corticosteroids are relevant ⁴. When a patient is prescribed long-term oral corticosteroids, it is important to be aware of potential side effects and the need for careful management ⁴. These can include a range of adverse effects, and the patient's care plan should address these ⁴. Furthermore, long-term corticosteroid use can lead to adrenal insufficiency, which requires careful identification and management ⁷. Patients on long-term corticosteroids should not stop treatment abruptly without medical advice due to the risk of adrenal crisis ⁴,⁷. Regular monitoring and a clear management plan are essential for patients receiving corticosteroid therapy ⁴.